Up against the wall.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 20526310.
- Also identified by DOI 10.1038/nm0610-628.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The notoriously drug-resistant bug MRSA has made headlines for years, but a whole other class of bacteria may prove even more troublesome. These microbes, Gram-negative bacteria, are increasingly a threat--and yet not a single late-stage drug in development specifically targets them. Christian Torres follows one man's quest to get the antibacterial pipeline flowing once again.
Medical subject headings
- Gram-Negative Bacteria
- Gram-Negative Bacterial Infections